Scientists call for more drugs, vaccines for multidrug-resistant TB

05/18/2010 | Reuters

Spending on research and development of drugs and vaccines for multidrug-resistant strains of tuberculosis should be increased as MDR-TB starts to advance in some countries, scientists said. Additional vaccines, treatments and diagnostic tests could reduce the global incidence of TB by 94% by 2050, they said.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
SPECIALIST II SYSTEMS INTEGRATION - 140000033P
Abbott
Dallas, TX
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
Teaching Associate (Hospitality Management)
University of Illinois at Urbana-Champaign
Urbana, IL
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Director, Global Regulatory Affairs
Rodan and Fields, LLC
San Francisco, CA